ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

This adverse event was reported 312 times

ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TIPRANAVIR 41 0.0344
1 CICLESONIDE 178 0.0173
2 ENFUVIRTIDE 41 0.0123
3 ACLIDINIUM BROMIDE 58 0.0104
4 GLYCOPYRROLATE 58 0.0099
5 TERBUTALINE SULFATE 10 0.0069
6 IPRATROPIUM BROMIDE 171 0.0060
7 MOXIFLOXACIN HYDROCHLORIDE 71 0.0057
8 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 150 0.0053
9 MEPOLIZUMAB 143 0.0052
See all drugs enriched for association with ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME

ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 143 0.0051
1 Stimulant Laxative [EPC] 39 0.0036
2 Polyene Antifungal [EPC] 40 0.0011
3 Anti-IgE [EPC] 61 0.0011
4 Leukotriene Receptor Antagonist [EPC] 18 0.0010
5 Protease Inhibitor [EPC] 41 0.0010
6 Human Immunoglobulin G [EPC] 7 0.0009
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 43 0.0009
8 Antimalarial [EPC] 6 0.0009
9 Cytochrome P450 3A Inhibitor [EPC] 41 0.0007
See all drug classes enriched for association with ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME